Publications by authors named "Joerg Halter"

Claim this Profile
B
Busulfan Once Versus Four Times Daily: Impact on Pharmacokinetics, Organ Toxicities and Survival After Allogeneic Hematopoietic Stem Cell Transplantation.
Claire Seydoux, Jakob R Passweg, Dominik Heim, Joerg Halter, Katharina M Rentsch

Transplant Cell Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.
Alexander Denk, Matthias Alexander Fante, Silke Heidenreich, Hildegard T Greinix, Eva-Maria Wagner Drouet, Joerg Halter

Transplant Cell Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation.
Marie Janscak, Anne Stelmes, Jana van den Berg, Dominik Heim, Joerg Halter

Bone Marrow Transplant· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
Khalil Ben Hassine, Claire Seydoux, Sonia Khier, Youssef Daali, Michael Medinger, Joerg Halter

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
Claire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, Tiago Nava, Joerg Halter

Bone Marrow Transplant· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pruritus in cutaneous graft-versus-host disease: A systematic review.
Jie Zhu, Alexander A Navarini, Joerg P Halter, Simon M Mueller

J Eur Acad Dermatol Venereol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.
Claire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, Tiago Nava, Joerg Halter

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease.
Christoph Tappeiner, Arnd Heiligenhaus, Joerg P Halter, Elisabetta Miserocchi, Francesco Bandello

Front Med (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation.
Claire Seydoux, Raphael Battegay, Joerg Halter, Dominik Heim, Katharina M Rentsch

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Hemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, Hassan B Alkhateeb, Susan Bal, Joerg Halter

Transplant Cell Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.
Zachariah DeFilipp, Daniel R Couriel, Aleksandr Lazaryan, Vijaya Raj Bhatt, Nataliya P Buxbaum, Joerg P Halter

Transplant Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association of travel time to transplant center and posttransplant care model with outcome parameters after allogeneic transplantation.
Raffaele Peter, Joerg P Halter, Dominik Heim, Michael Medinger, Thomas Pabst

Bone Marrow Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ounce of which prevention is worth a…?
Joerg Halter, Jakob Passweg

Blood· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial.
Claire Seydoux, Michael Medinger, Sabine Gerull, Joerg Halter, Dominik Heim

Ann Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
Beatrice Drexler, Felicitas Zurbriggen, Tamara Diesch, Romaine Viollier, Joerg P Halter

Ann Hematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of CMV Replication and the Role of Letermovir Primary/Secondary Prophylaxis in the Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation - A Single Centre Study.
Ursina Studer, Nina Khanna, Karoline Leuzinger, Hans H Hirsch, Dominik Heim, Joerg Halter

Anticancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study.
Diem-Lan Vu, Julie-Anne Dayer, Stavroula Masouridi-Levrat, Christophe Combescure, Elsa Boely, Joerg Halter

Transpl Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease Classification.
Olivia E O'Leary, Andreas Schoetzau, Ludovic Amruthalingam, Nadine Geber-Hollbach, Kim Plattner, Joerg P Halter

Transl Vis Sci Technol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracorporeal Photopheresis in Graft-versus-Host Disease.
Beatrice Drexler, Andreas Buser, Laura Infanti, Gregor Stehle, Joerg Halter

Transfus Med Hemother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis.
Christoph Bucher, Joerg Halter, Jakob Passweg

Lancet Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory viral infections prior to and after allogeneic haematopoietic cell transplantation.
Jakob R Passweg, Nina Khanna, Joerg Halter

Br J Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study.
Ali Bazarbachi, Myriam Labopin, Giorgia Battipaglia, Azedine Djabali, Edouard Forcade, Joerg Halter

Clin Hematol Int· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Elisabeth Wehrle-Wieland, Kristina Affolter, Daniel Goldenberger, Sarah Tschudin Sutter, Joerg Halter

Transpl Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonogenic versus morphogenic mutations in myeloid neoplasms: chronologic observations in a U2AF1, TET2, CSF3R and JAK2 'co-mutated' myeloproliferative neoplasm suggest a hierarchical order of mutations and potential predictive value for kinase inhibitor treatment response.
Magdalena M Gerlach, Pontus Lundberg, Joerg Halter, Christian Arranto, Friedel Wenzel

Leuk Lymphoma· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34 Yields Are Less.
David F Stroncek, Bronwen E Shaw, Brent R Logan, Deidre M Kiefer, Bipin N Savani, Joerg Halter

Biol Blood Marrow Transplant· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis